Work

The case for soluble Aβ oligomers as a drug target in Alzheimer's disease

Year: 2013

Type: review

Source: Trends in Pharmacological Sciences

DOI: 10.1016/j.tips.2013.03.002

Authors: Franz Hefti, William F. Goure, Jasna Jerecic, Kent S. Iverson, Patricia A. Walicke, Grant A. Krafft

Institution: Acumen Pharmaceuticals (United States)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1994898376

FWCI: 1.405

Cites: 69

Cited by: 121

Related to: 10